The present discovery of this novel NGF/Nrf2/HO‐1 pathway and ROS–JNK/c‐Jun pathway identifies new clinical targets for therapeutic intervention of Alzheimer's disease. This evidence concerns the gene MAPK8 and Alzheimer disease.